share_log

Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)

SEC ·  Nov 18 16:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more